As one of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its capabilities.
The company has hit a number of milestones recently, including updated CGMs, new AI capabilities, expanded partnerships and more.
Speaking to Drug Delivery Business News at the American Diabetes Association’s 85th Scientific Sessions in Chicago, Dexcom President and COO Jake Leach explained how the company continues to drive interest in its sensor platforms.
“The volume of CGM data at this conference shows the outcomes that this technology can provide,” Leach said. “There are still so few people that are using it, even globally. We’ve really just got to continue to drive awareness and access to this product and technology.”
Get the full story at our sister site, Drug Delivery Business News.
